secwatch.observer — SEC 8-K summary
======================================

Issuer:     Amylyx Pharmaceuticals, Inc. (AMLX)
CIK:        0001658551
Form:       8-K
Filed at:   2023-03-21T23:59:59+00:00
Accession:  0001193125-23-075821
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Amylyx appoints Karen Firestone to board of directors, effective March 16, 2023
-------------------------------------------------------------------------------

- Karen Firestone appointed as Class I director effective March 16, 2023.
- Will serve on Audit Committee and Nominating and Corporate Governance Committee.
- Eligible for annual cash retainer of $45,000 plus committee retainer fees.
- Granted initial option for 27,403 shares; one-third vests in 1 year, balance over 2 years.
- Director compensation policy amended January 20, 2023, filed as exhibit.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1658551/000119312523075821/0001193125-23-075821-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1658551/000119312523075821/d452110d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-075821

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer